candidate

Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDAPress Release: Chlamydia vaccine candidate granted fast track designation by the US FDA

Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA

Chlamydia vaccine candidate granted fast track designation by the US FDA Chlamydia infection can contribute to pelvic inflammatory diseases in…

7 days ago
Bioxodes obtains Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and EuropeBioxodes obtains Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe

Bioxodes obtains Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe

FDA, EMA grant BIOX-101 ODD status to treat intracerebral hemorrhagic stroke (ICH)ODD status may expedite drug candidate development and approvals…

4 weeks ago
IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO ConferenceIO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference

IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference

February 23, 2025 12:07 ET  | Source: IO Biotech • Findings support the development of a novel peptide vaccine targeting…

1 month ago
Comanche Biopharma Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway (ILAP) Steering Group for CBP-4888, an Investigational siRNA Drug Candidate for the Treatment of sFlt1-mediated Preterm PreeclampsiaComanche Biopharma Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway (ILAP) Steering Group for CBP-4888, an Investigational siRNA Drug Candidate for the Treatment of sFlt1-mediated Preterm Preeclampsia

Comanche Biopharma Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway (ILAP) Steering Group for CBP-4888, an Investigational siRNA Drug Candidate for the Treatment of sFlt1-mediated Preterm Preeclampsia

January 30, 2025 05:00 ET  | Source: Comanche Biopharma ILAP aims to accelerate time to market, facilitating faster patient access…

2 months ago
Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis BAssembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing observed – – In the…

3 months ago
Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibioticsBasilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

Additional funding awarded following successful drug candidate nominationUSD 7.3 million to support progression of antibiotic BAL2420 (LptA inhibitor) towards first-in-human…

3 months ago
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease PatientsSerina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease Patients

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease Patients

HUNTSVILLE, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced…

4 months ago

IOC Ethics Commission draws lots to determine order of presidential candidate presentations

26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…

4 months ago

IOC Ethics Commission draws lots to determine order of presidential candidate presentations

26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…

4 months ago

IOC Ethics Commission draws lots to determine order of presidential candidate presentations

26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…

4 months ago
Show more Posts